One of the nation’s largest, most advanced cancer research and treatment organizations, City of Hope is home to a National Cancer Institute-designated comprehensive cancer center with the highest possible “exceptional” rating. Ranked among the top hospitals for cancer care by U.S. News & World Report and the no. 1 in Southern California, City of Hope is known for transforming research into treatments for cancer and related life-threatening illnesses, including diabetes, sickle cell and HIV. Its scientists have pioneered breakthroughs such as monoclonal antibodies, the foundational technology for human synthetic insulin, and next-generation immunotherapies that now benefit more than 100 million people worldwide. With more than 2,000 scientists and clinicians, City of Hope leverages state-of-the-art laboratories and on-site biomanufacturing to accelerate CAR T cell therapies and advanced cellular treatments from discovery to patient care at unprecedented speed. A partnership with the Translational Genomics Research Institute also expands its precision medicine capabilities. Committed to increasing access to advanced cancer treatments, City of Hope operates cancer centers in five major U.S. metropolitan areas and has developed one of the nation’s most advanced clinical trial networks, ensuring more people participate in promising investigational studies. One of the largest philanthropic organizations in cancer medicine enables City of Hope to continue advancing discoveries year-after-year, expand access to care and ensure that lifesaving treatments reach more people, faster.
